Clinical Report: Development of a Silk Fibroin-Chitosan Scaffold-Based Tubular Graft

Overview

This study evaluates the feasibility of using bone marrow mesenchymal stem cells (BMSCs) and silk fibroin/chitosan (SF/CS) scaffolds to create tissue-engineered tubular grafts for urinary diversion in a rabbit model.

Background

Urinary diversion procedures often require the use of gastrointestinal segments, which can lead to significant long-term complications.

Data Highlights

Key Findings

• BMSCs showed high expression of CD44 and CD90, indicating stem cell characteristics.
• BMSCs differentiated into urothelium-like cells expressing specific proteins such as UP1A, CK7, and CK13.
• All rabbits in the experimental group survived and showed luminal urothelial growth.
• Immunohistochemistry confirmed the presence of mature epithelial cells in the grafts.
• Control grafts resulted in mortality due to collapse by week 4.

Clinical Implications

The study presents findings on the use of BMSCs in urinary tissue engineering.

Conclusion

The findings demonstrate the feasibility of using BMSC-derived urothelium-like cells in tissue-engineered grafts for urinary diversion.

Related Resources & Content

1. Advancements in Urethral Tissue Engineering: Current Status as of 2019
2. Impact of Cyclic Uniaxial Strain on Cells in the Urinary Bladder
3. Utilization of Stromal Vascular Fraction Cells as a Biological Coating for Hernia Repair Mesh
4. EAU Guidelines on MIBC - Introduction
5. Bone Marrow Transplantation — Targeted Intra-Arterial Delivery of Umbilical Cord Blood to Bone Marrow in Animal Models
6. EAU Guidelines on MIBC - Introduction
7. Long-Term Complications and Quality of Life After Urinary Diversion for Bladder Cancer: A Systematic Review and Meta-Analysis - PMC
8. Frontiers | Evaluation of silk fibroin-based urinary conduits in a porcine model of urinary diversion